), 2.3-fold higher than the wild type. A de novo UDP-Xyl biosynthetic pathway was constructed, enabling intracellular cofactor regeneration. Under optimized conditions, a titer of 4451 mg/L with an 87% conversion rate was achieved.
Xu et al. (2026) studied this question.